Skip to content
Clinical Trials – home
Universitaetsspital Basel
Sponsor

Universitaetsspital Basel

Petersgraben 4, 4031

About the sponsor

Clinical research includes aortic stenosis and peri-procedural management in patients undergoing TAVR, with interest in cardiovascular optimisation around valve intervention.

  • Aortic stenosis
  • Transcatheter aortic valve replacement
  • Beta blocker therapy

The sponsor is also involved in studies examining medication use in the setting of structural heart disease and valve replacement care.

About Specializations

Universitaetsspital Basel runs clinical trials in conditions such as Osteoarthritis, Aortic stenosis, Diabetes insipidus, Atrial fibrillation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Aortic stenosis

Recruiting

Study of beta blockers in patients with aortic stenosis undergoing transcatheter aortic valve replacement

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:Universitaetsspital Basel

Osteoarthritis

Recruiting

Study on Treating Knee Osteoarthritis with Nasal Cartilage Implantation for Patients with Patellofemoral Osteoarthritis

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:N-Tec
  • Sponsor:Universitaetsspital Basel

Study on Oxytocin Nasal Spray for Patients with Central Diabetes Insipidus

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Universitaetsspital Basel

Osteoarthritis

Recruiting

Study on Treating Knee Osteoarthritis with N-TEC Implant for Patients with Patellofemoral Osteoarthritis

InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:N-Tec
  • Sponsor:Universitaetsspital Basel

Atrial fibrillation

Not yet recruiting

Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Universitaetsspital Basel

Ischaemic stroke

Not yet recruiting

Study of dabigatran, apixaban and edoxaban for prevention of stroke recurrence in patients with acute ischemic stroke without known atrial fibrillation

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Universitaetsspital Basel

Hyponatraemia

Not recruiting

Study on the Effects of Empagliflozin in Patients with Euvolemic and Hypervolemic Hyponatremia

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Universitaetsspital Basel

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.